In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution

被引:49
作者
Diedrich, B. [1 ]
Sandgren, P. [1 ]
Jansson, B. [2 ]
Gulliksson, H. [3 ]
Svensson, L. [4 ]
Shanwell, A. [3 ]
机构
[1] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, SE-14186 Stockholm, Sweden
[2] Karolinska Univ Hosp Huddinge, Dept Hosp Pharm, SE-14186 Stockholm, Sweden
[3] Karolinska Univ Hosp Huddinge, Dept Clin Immunol & Transfus Med, SE-14186 Stockholm, Sweden
[4] Karolinska Univ Hosp Huddinge, Dept Hosp Phys, SE-14186 Stockholm, Sweden
关键词
apheresis platelets; chromium; indium; platelet additive solution; platelet storage;
D O I
10.1111/j.1423-0410.2007.01002.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objective Prolonged storage of platelets up to 7 days provides improved availability, logistical management and decreased wastage. Beside methods of bacterial detection, addition of magnesium and potassium to the platelet storage solution (SSP+) may further improve the quality of platelets with extended storage. Materials and Methods Apheresis platelets from 10 donors were divided and stored in two different platelet additive solutions (PAS) (Intersol and SSP+) for a paired comparison. A variety of in vitro platelet function and metabolic assays were performed both on day 1 and after 7 days of storage. For in vivo study, platelets were labelled with either (111)Indium or (51)Chromium after 7 days of storage and were injected into the corresponding donor. Serial blood samples were drawn for recovery and survival measurements. Results In vitro parameters for SSP+ showed significantly reduced glycolysis (lower glucose consumption and decreased production of lactate), a higher hypotonic shock response (HSR) and the extent of shape change reactivity and a lower degree of platelet activation by means of RANTES (regulated on activation, normal, T cell-expressed, and secreted), CD62p and CD63 expression. Platelet recovery on day 7 was higher for Intersol as compared to SSP+, 65 +/- 11 vs. 53 +/- 13% (P = 0.023), and survival showed no difference 4.2 +/- 1.9 vs. 3.6 +/- 1.4 days. Conclusion In vitro characteristics of platelets stored in PAS with addition of potassium and magnesium indicated higher quality, but this could not be verified by the in vivo parameters by means of recovery and survival.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 50 条
  • [1] Evaluation of a CD61 MoAb method for enumeration of platelets in thrombocytopenic patients and its impact on the transfusion decision-making process
    Arroyo, JL
    García-Marcos, MA
    López, A
    Menéndez, P
    Tabernero, MD
    Sánchez-Abarca, LI
    Avila-Zarza, C
    San Miguel, JF
    Orfao, A
    [J]. TRANSFUSION, 2001, 41 (10) : 1212 - 1216
  • [2] The rationale for a standardized approach to assessment of platelet kinetics
    AuBuchon, James P.
    Snyder, Edward L.
    [J]. TRANSFUSION, 2006, 46 (03) : 44S - 48S
  • [3] Further evaluation of a new standard of efficacy for stored platelets
    AuBuchon, JP
    Herschel, L
    Roger, J
    [J]. TRANSFUSION, 2005, 45 (07) : 1143 - 1150
  • [4] P-selectin and platelet clearance
    Berger, G
    Hartwell, DW
    Wagner, DD
    [J]. BLOOD, 1998, 92 (11) : 4446 - 4452
  • [5] Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178
  • [6] Bertolini F, 2000, TRANSFUSION, V40, P121
  • [7] ROLE OF LACTATE IN PLATELET STORAGE LESION
    BERTOLINI, F
    PORRETTI, L
    LAURI, E
    REBULLA, P
    SIRCHIA, G
    [J]. VOX SANGUINIS, 1993, 65 (03) : 194 - 198
  • [8] BERTOLINI F, 1994, TRANSFUSION, V34, P802
  • [9] BODE AP, 1990, BLOOD CELLS, V16, P109
  • [10] Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice?
    Boehlen, F
    Clemetson, KJ
    [J]. TRANSFUSION MEDICINE, 2001, 11 (06) : 403 - 417